No, I am NOT going to sell a single share of ABBV or ABT.
There is a disconnect between the way I perceive the world around me vs. some other folks. I like to bring forward the most controversial assertions, hypotheses, views to stir the proverbial pot. Most folks here are just dumb traders on both sides of the divide... I don't care for their dogmatic nonsense.
Best to you.
183 US and International patents issued. 91 publications in refereed journals, last one few months ago in Angew. Chemie.
Started 5 companies. What data do you want ex-Volwiler Fellow? They were giving Volwiler Fellowships to some pretty incompetent fellow, you know I am right.
I am not a trader, I am a scientist. best to you, don't have more time for you.
Watch my hear beating fast after reading about your Volwiler Society. You Rottweilers are notoriously incompetent. I turned many of your\Rottweilers when you interviewed at my companies.
BTW, I publish in A.Am. Chem. Soc., Angew. Chemie, etc.
I spent my lifetime in drug discovery. You repeat how experienced you are in this area but.. in my long life as a scientist entrepreneur I have seen my dose of shysters.
You don't strike me as a scientist. You are a marketing p uke
Amgen is very advanced in producing adalimumab biosimilar. Others too. As usual your wishful thinking obscures your mind.
is a disaster for ABBV investors. Here is an excellent analysis:
Fact #1: ABBV paid 21 billion
Fact #2: Closest bidder JNJ offered $18 billion.
Fact #3: that's 3billion difference.
Fact #4: THAT'S NOT CLOSE by any financial criteria.
Now you may GFY.
Bets were close to each other??? 3billion $ is not "close". The capacity of the trolls on this MBfor self-delusion is truly amazing...